Executive Summary
This U.S. M&A and takeover digest spans 11 filings, with a heavy concentration of SPAC activity alongside significant corporate transformations and asset acquisitions. The most critical development is Honeywell's completion of its Aerospace Technologies spin-off, a major strategic pivot that creates three independent, focused leaders and is expected to unlock substantial shareholder value through a pure-play structure.
The period also saw a landmark transaction in the real assets management sector, where CIM Real Estate Finance Trust acquired CIM Group's business in a deal that values the combined entity's assets at over $30 billion, though existing CMFT shareholders were diluted to a 32.5% stake. Another notable M&A theme is the trend of early-stage biotech de-SPACs, exemplified by Talawar Therapeutics' merger with JATT II Acquisition Corp, which is bolstered by a massive $285 million in proceeds including an oversubscribed $225 million PIPE. On the lower end of the materiality spectrum, several SPACs are merely extending deadlines or completing administrative steps, such as unit separations, reflecting a challenging environment for finding viable targets. Blue Owl's acquisition of a data center facility in Virginia underscores the growing appetite for digital infrastructure assets. A significant risk flag is raised by Acura Pharmaceuticals, whose debt load has ballooned by 361% since 2022, indicating severe financial distress. Overall, the quarter ended with a clear bifurcation: high-conviction, well-capitalized M&A (Honeywell, Talawar/JATT, Blue Owl) versus capital-constrained, deadline-driven SPACs (CSTAF, Alpex).
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Merger & Acquisition SEC Filings digest from June 22, 2026.
Investment Signals (8)
- Honeywell International ↓ (BULLISH)▲
Spin-off of Aerospace Technologies creates three independent, focused market leaders; coupled with a 1-for-2 reverse stock split, this is a significant value-unlocking event for shareholders through pure-play exposure
- Talawar Therapeutics / JATT II (BULLISH)▲
De-SPAC with a $285 million war chest ($225M oversubscribed PIPE), providing a clear funding runway through a Phase 2b readout in H2 2028 for lead candidate TALA-125, which enters the clinic in Q1 2027
- CIM Real Estate Finance Trust ↓ (BULLISH)▲
Acquired CIM Group's real assets management business, creating a combined entity managing over $30B in assets; the company has committed to pursue a stock exchange listing within 24 months, a potential liquidity catalyst for current shareholders
- Blue Owl Digital Infrastructure Trust ↓ (BULLISH)▲
Acquired a data center facility in the hyperscale data center hub of Gainesville, VA, indicating a strategic push into high-demand digital infrastructure, a sector with robust secular tailwinds
- Quantum Leap Acquisition Corp ↓ (BULLISH)▲
Fully exercised its over-allotment, raising total IPO gross proceeds to $230M, signaling strong investor demand. Focus on AI and quantum computing aligns with a high-growth thematic, increasing the pool of potential high-quality targets
- Made in USA Inc. ↓ (BULLISH)▲
Acquired a suite of IP and technology assets (AI, blockchain, IoT) from an affiliate for no cash, strategically positioning to build a verified U.S. manufacturing ecosystem, which is a strong narrative in the current geopolitical climate
-
Drew only $5,000 to fund a one-month extension, the fifth of eleven allowed. This suggests a low-cost, cash-preserving strategy as it continues its search, but the ticking clock and OTC listing signal a struggle to close a deal [NEUTRAL/BEARISH]
- Alpex Acquisition Corp ↓ (NEUTRAL)▲
Successfully priced a $100M SPAC IPO at $10/unit, a positive signal for the SPAC IPO market's viability, providing a clean, well-capitalized platform for an unidentified target
Risk Flags (9)
- Acura Pharmaceuticals / Debt Load↓ [HIGH RISK]▼
Aggregate principal on its secured promissory note has skyrocketed by 361% from $2.3M to $10.7M through 62 additional loans since 2022, including a $200K loan added just days ago, indicating a critical cash burn and reliance on lender support
- ▼
Existing CMFT shareholders were diluted to a mere 32.5% voting and economic ownership of the combined entity, with CIM Group, LLC receiving 67.5%, representing a significant shift in control and economic exposure
-
Auditor change occurs amidst prior reports containing a going concern explanatory paragraph and disclosed material weaknesses in internal controls, raising serious concerns about financial stability and reporting integrity
- JATT II Acquisition Corp / De-SPAC Redemption Risk↓ [MEDIUM RISK]▼
The Talawar Therapeutics business combination is subject to shareholder approval and potential redemptions by JATT II public shareholders, which could materially reduce the available cash from the trust and jeopardize the deal's economics
- Constellation Acquisition Corp I / Looming Deadline↓ [MEDIUM RISK]▼
Continues to operate on the OTC Pink market and has only 6 of 11 permitted one-month extensions remaining (until December 2026), increasing the probability of a forced low-quality acquisition or liquidation if a deal is not found
- Alpex Acquisition Corp / High-Risk SPAC Model↓ [MEDIUM RISK]▼
As a blank-check company with no target identified, it carries inherent risk of value destruction if it acquires an overvalued or poor-performing business within the limited 18-24 month timeframe
- Made in USA Inc. / Affiliate Transaction & Liquidity↓ [MEDIUM RISK]▼
The acquisition was between affiliates with no arm's-length negotiation. Consideration was restricted stock with no cash flow impact, and as an OTC stock, there is limited investor visibility and liquidity
- Quantum Leap Acquisition Corp / Lack of Target↓ [LOW-MEDIUM RISK]▼
Despite a large $230M war chest, the SPAC has not announced a business combination. The leadership's focus on China-excluded AI/quantum targets narrows the pipeline and could delay a deal
- ▼
The unit separation announcement is a purely administrative step with no material business progress, indicating a continued lack of a definitive business combination
Opportunities (7)
- Honeywell International / Pure-Play Spin-off↓ (OPPORTUNITY)◆
The completed Aerospace Technologies spin-off creates a pure-play aerospace and defense investment, likely to command a higher valuation multiple compared to its former conglomerate structure. Monitor initial trading for potential price discovery dislocation
- Talawar Therapeutics / Well-Funded Biotech Catalyst (OPPORTUNITY)◆
With $285M in proceeds, the combined company is well-funded through a pivotal data readout. Key catalysts include initiating Phase 1 trials for TALA-125 in Q1 2027 and interim data in Q4 2027, providing potential for significant upside
- CIM Group (formerly CMFT) / Future Listing Catalyst (OPPORTUNITY)◆
The commitment to pursue a stock exchange listing within 24 months could lead to a significant valuation re-rate as the company transitions from a non-traded REIT to a publicly listed entity, offering a liquidity event for current holders
-
Acquisition of a data center in Northern Virginia's dominant data center market positions the company for strong secular growth from cloud and AI demand. The undisclosed purchase price and tenant lease may offer upside if terms are favorable
- Quantum Leap Acquisition Corp / Thematic M&A Pipeline↓ (OPPORTUNITY)◆
The $230M SPAC with a focus on AI and quantum computing targets represents a dedicated structure for investors seeking exposure to a high-growth M&A theme. A successful combination could provide a fast-tracked public listing for a private company in this space
- Made in USA Inc. / 'Made in USA' Theme↓ (OPPORTUNITY)◆
The stock (OTC: USDW) now holds a portfolio of IP and domain names centered on verified U.S. manufacturing. With increasing national focus on supply chain reshoring, this could become a high-conviction thematic play, though liquidity is a concern
- Alpex Acquisition Corp / Well-Priced SPAC IPO↓ (OPPORTUNITY)◆
At $10/unit, this is a standard but clean SPAC structure. For sophisticated investors, participating in a SPAC IPO offers downside protection via trust value with upside optionality from a future business combination
Sector Themes (5)
- SPAC Market Persists Despite Headwinds◆
The digest shows a resilient but varied SPAC market: three new SPACs raising capital (Alpex, Quantum Leap) versus several others struggling to find targets and resorting to extensions (CSTAF) or completing administrative tasks (Aeon). This suggests a two-tier market where well-themed, well-managed SPACs can succeed, while others face liquidation pressure.
- Strategic Divestitures and Spin-Offs as Value Creators◆
Honeywell's spin-off is a prime example of conglomerate break-up value unlocking. The market is rewarding companies that focus on core operations, with pure-play companies often trading at premium valuations. This trend is likely to continue as management teams seek to optimize portfolios.
- Massive Capital Infusion into Early-Stage Biotech◆
The Talawar/JATT deal represents a significant capital commitment to early-stage biotech via the de-SPAC route. The $225M oversubscribed PIPE signals strong institutional appetite for de-risked, platform-based biotech assets, particularly in high-growth fields like immunology.
- Data Center & Digital Infrastructure M&A Accelerating◆
Blue Owl's data center acquisition in the 'Data Center Alley' of Virginia confirms the intense demand for physical digital infrastructure. Expect more M&A in this space as cloud providers and funds compete for prime, powered real estate assets.
- Distressed Financing vs. Strategic M&A◆
The data shows a clear divergence: healthy companies execute transformative spin-offs and well-funded acquisitions, while distressed companies like Acura Pharmaceuticals rely on repeated, high-interest loans for survival. Investors should focus on balance sheet strength to differentiate winners from value traps.
Watch List (8)
- Talawar Therapeutics / JATT II👁
Watch for the shareholder vote to approve the business combination and for any PIPE redemptions. Key catalysts are the start of TALA-125 Phase 1 trials in Q1 2027 [Upcoming months]
- CIM Group (formerly CMFT)👁
Monitor for any filing updates regarding the 24-month timeline for a stock exchange listing and the initial quarterly dividend commitment. The company's capital allocation strategy post-merger is crucial [Long-term, within 24 months]
-
Monitor the initial trading volume and price action of the newly spun-off Honeywell Aerospace (AER) to assess market reception and identify any dislocation from the parent company [Immediate, next few trading days]
-
Watch for additional loan amendments or a potential default as its debt continues to mount. Any news on a strategic alliance or asset sale would be critical, as the current trajectory suggests a high risk of restructuring [Near-term]
-
With only 6 extensions left, its deadline is July 29, 2026. Any announcement of a definitive agreement or a further extension request will be a material event for its OTC-listed securities [Before July 29, 2026]
-
Monitor for any 8-K announcing a letter of intent or definitive agreement for a business combination, as the large $230M trust provides a powerful acquisition currency [Unknown, likely in the next 6-12 months]
-
Watch for any subsequent filings disclosing the purchase price and the identity/sector of the tenant for the Gainesville data center, which would be critical for valuation analysis [Ongoing]
-
Monitor the next 10-Q filing for an opinion from new auditor Simon & Edward LLP regarding the going concern status and any changes to the previously reported material weaknesses in internal controls [Next quarterly filing]
Filing Analyses
(11)
29-06-2026
Honeywell Technologies has completed the spin-off of its Aerospace Technologies business, which now operates as Honeywell Aerospace, effective June 29, 2026. This transaction, along with the previously separated Solstice Advanced Materials, completes Honeywell’s transformation into three independent, focused market leaders. Alongside the spin-off, Honeywell Technologies executed a 1-for-2 reverse stock split, reducing outstanding shares from approximately 634 million to about 317 million.
- · The spin-off distribution ratio was one share of Honeywell Aerospace common stock for every two shares of Honeywell Technologies common stock held as of the record date of June 15, 2026.
- · Honeywell Technologies common stock received a new CUSIP number (438516205) following the reverse split.
- · The number of authorized shares of Honeywell Technologies common stock was reduced from 2 billion to 1 billion concurrently with the reverse split.
- · Honeywell Technologies will file a supplemental 8-K later today presenting the Aerospace business as discontinued operations and providing recast quarterly financials for FY2024, FY2025, and Q1 2026.
- · No fractional shares were issued; cash will be provided in lieu of fractional shares for both the spin-off and reverse split.
- · Both the spin-off and reverse stock split were previously announced and completed simultaneously on June 29, 2026.
- · Honeywell Technologies will continue to trade under the ticker 'HON', while Honeywell Aerospace will trade under 'HONA'.
29-06-2026
CIM Real Estate Finance Trust, Inc. (CMFT) acquired CIM Group, LLC's real assets management business and portfolio of investments, forming a combined company renamed CIM Group, Inc. The combined entity manages over $30 billion in assets and will operate as a diversified owner, operator, lender, developer and real assets management platform. CIM Group, LLC received 67.5% voting and economic ownership of the combined company, while existing CMFT shareholders hold the remaining 32.5%. The company will not be treated as a REIT for U.S. tax purposes and has committed to pursue a stock exchange listing within 24 months.
- · The transaction was unanimously approved by a Special Committee of CMFT's Board of Directors composed exclusively of independent directors, and by the full Board.
- · The combined company has committed to fund quarterly dividends over the next three years.
- · A majority-independent Board is expected, with existing CMFT Independent Directors continuing in their roles.
- · The combined company will continue regulatory reporting obligations, including annual, quarterly and periodic filings.
- · The combined company has committed to commence a process within 24 months to pursue a future listing of its common stock on a national stock exchange and to seek to complete such listing or an alternative liquidity event within five years.
- · Advisors: Goldman Sachs & Co. LLC (financial advisor) and Venable LLP (legal advisor) to the Special Committee; Taft Stettinius & Hollister LLP (legal advisor) to CMFT; Sullivan & Cromwell LLP (legal advisor) to CIM Group, LLC.
29-06-2026
Alpex Acquisition Corporation, a blank check company, announced the pricing of its $100 million initial public offering of 10,000,000 units at $10.00 per unit, with the units expected to trade on Nasdaq under 'ALPXU' starting June 25, 2026. The offering, managed by D. Boral Capital LLC, includes a 45-day over-allotment option for up to 1,500,000 additional units and is expected to close on June 26, 2026. As a SPAC, Alpex has not yet identified a target business combination, and the forward-looking statements highlight risks that the offering may not be completed as described.
- · The underwriters have a 45-day option to purchase up to 1,500,000 additional units to cover over-allotments.
- · Upon separate trading, Class A ordinary shares, warrants, and rights are expected to be listed under 'ALPX', 'ALPXW', and 'ALPXR' respectively.
- · The registration statement on Form S-1 (File No. 333-294978) was declared effective by the SEC on June 24, 2026.
- · Alpex is a blank check company with no target industry or geographic region limitation for its business combination search.
29-06-2026
Constellation Acquisition Corp I drew $5,000 from an existing unsecured promissory note to fund a one-month extension of its deadline to complete an initial business combination from June 29, 2026 to July 29, 2026. This is the fifth of eleven permitted one-month extensions. The note does not bear interest and will only be repaid from amounts remaining outside the trust account if no deal closes.
- · The Company's securities are traded on the OTCID Basic Market under symbols CSTAF (Class A ordinary shares), CSTWF (warrants), and CSTUF (units).
- · The warrant exercise price is $11.50 per whole warrant for one Class A ordinary share.
- · The promissory note is dated January 30, 2024 and is unsecured.
- · In the event no business combination is consummated, the note will be repaid only from amounts remaining outside the trust account, if any.
29-06-2026
Acura Pharmaceuticals, Inc. disclosed an amended loan schedule to a Secured Promissory Note dated November 10, 2022, with Abuse Deterrent Pharma, LLC. The aggregate principal has increased from $2,319,279 to $10,694,279 through 62 additional loans made between December 2022 and June 2026, with the most recent loan of $200,000 added on June 24, 2026. The filing indicates ongoing financial support from the lender, but also highlights Acura's continued reliance on debt financing.
- · The original promissory note was dated November 10, 2022, with an initial principal of $2,319,279.
- · Loans #1 through #50 (Dec 22, 2022 to Dec 31, 2025) added $7,075,000, bringing the aggregate to $9,394,279.
- · Subsequent loans #51 through #62 (Jan 2, 2026 to Jun 24, 2026) added $1,300,000, with the final loan of $200,000 on June 24, 2026.
- · The total increase in debt from the original note is $8,375,000 over approximately 3.5 years.
29-06-2026
On June 29, 2026, Aeon Acquisition I Corp. announced that holders of its units may elect to separately trade the underlying Class A ordinary shares, warrants, and rights starting on or about July 1, 2026. The separate securities will trade on NASDAQ under symbols AESP, AESPW, and AESPR, while units not separated will continue under the symbol AESPU. This is an administrative step and does not involve any financial results or material business combination.
- · The press release detailing the separation is attached as Exhibit 99.1.
- · Units not separated will continue trading under symbol AESPU.
29-06-2026
Quantum Leap Acquisition Corp fully exercised its over-allotment option, selling an additional 3,000,000 units at $10.00 per unit, bringing total IPO units to 23,000,000 and aggregate gross proceeds to $230,000,000. The securities began separate trading on the NYSE on June 23, 2026. The company, a blank check SPAC, intends to focus on AI, quantum computing, and blockchain targets, but has not yet announced a business combination.
- · The company is a blank check SPAC focused on AI, quantum computing, and blockchain targets, excluding China, Hong Kong, Taiwan, and Macau.
- · The leadership team has over six decades of combined experience in AI, quantum computing, cybersecurity, and blockchain.
- · The registration statement (File No. 333-293359) was declared effective on April 30, 2026.
- · The underwriters' over-allotment option was exercised in two tranches: 917,392 units on May 12, 2026, and the remaining 2,082,608 units on June 22, 2026.
29-06-2026
Blue Owl Digital Infrastructure Trust, through its subsidiary NVA11A LLC, has entered into a Membership Interest Purchase Agreement to acquire a data center facility located at 13760 University Boulevard in Gainesville, Virginia from US GCDC Phase 1 Holdings LLC. The transaction includes the land, improvements, a lease with an undisclosed tenant, and various project agreements such as an Energy Services Agreement with Dominion Energy and a Memorandum of Understanding with the Virginia Economic Development Partnership Authority. The purchase price is not disclosed in the filing.
- · The property is a data center facility located at 13760 University Boulevard, Gainesville, Virginia 20155.
- · The seller is US GCDC Phase 1 Holdings LLC, and the purchaser is NVA11A LLC, a subsidiary of Blue Owl Digital Infrastructure Trust.
- · The property is subject to a lease with an undisclosed tenant, and the purchaser will acquire the lease along with security deposits.
- · The transaction includes an Energy Services Agreement with Dominion Energy Virginia and a Memorandum of Understanding with the Virginia Economic Development Partnership Authority.
- · Certain project agreements may require third-party consents for assignment, and the seller will use commercially reasonable efforts to obtain them.
- · The property is subject to a Declaration of Covenants, Conditions and Restrictions recorded in Prince William County, Virginia.
- · The agreement includes standard representations and warranties, and the seller is not required to assign certain excluded contracts such as insurance, property management, and attorney engagements.
29-06-2026
Talawar Therapeutics and JATT II Acquisition Corp (Nasdaq: JATT) announced a definitive business combination agreement to create a publicly listed biotechnology company focused on bispecific antibodies for immunology and inflammatory diseases. The combined company expects to receive $285 million in proceeds, including a $225 million oversubscribed PIPE led by Access Biotechnology, to fund lead candidate TALA-125 through a Phase 2b proof-of-concept data readout in the second half of 2028. However, the transaction is subject to shareholder and regulatory approvals, and the combined company will face risks typical of early-stage biotech, including clinical development uncertainties and potential redemptions by JATT II public shareholders.
- · TALA-125 is expected to enter the clinic in Q1 2027, with interim Phase 1 data anticipated in Q4 2027.
- · The PIPE is priced at $10.00 per share.
- · Talawar was formed as the first company by Khanda Therapeutics, L.P.
- · The combined company is expected to trade on Nasdaq under ticker 'TLWR'.
- · Transaction is expected to close in the second half of 2026, subject to JATT II shareholder approval and regulatory approvals.
- · Advisors for the PIPE include Guggenheim Securities, Cantor, and LifeSci Capital.
29-06-2026
Made in USA Inc. (OTC: USDW) completed a $25 million all-stock acquisition of intellectual property and other assets from affiliate Made in USA One LLC, issuing 5,000,000 shares as consideration. The transaction consolidates over 28 years of certification expertise with a technology platform—including blockchain, AI, IoT, and DataWallet™—to build a verified U.S. manufacturing ecosystem. As an acquisition between affiliates and a small public company, no revenue or profit impact was disclosed, and the shares are restricted under Rule 144.
- · Acquisition was of assets from an affiliate under common control – no arm's-length negotiation implied.
- · No cash consideration was paid; only restricted stock (Rule 144) was issued.
- · Assets include 65 premium domain names, blockchain/Hyperledger infrastructure, ERP/IoT systems, and AI-enabled verification tools.
- · The Company expects the transaction to be reflected in its quarterly reporting.
- · No forward-looking guidance on revenue, earnings, or customer pipeline was provided.
29-06-2026
WinVest Acquisition Corp. (WINVW) dismissed BCRG Group as its independent auditor and appointed Simon & Edward LLP (S&E) after S&E acquired BCRG's attest business effective June 15, 2026. The change was approved by the Audit Committee on June 23, 2026, with no disagreements or reportable events between the company and BCRG, though BCRG's prior audit reports included a going concern explanatory paragraph for fiscal years 2024 and 2025, and material weaknesses in internal controls were previously disclosed.
- · BCRG's audit reports for fiscal years ended December 31, 2025 and 2024 contained no adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles, except for a going concern explanatory paragraph.
- · Material weaknesses in internal control over financial reporting were previously disclosed under Part II, Item 9A of the 2025 Annual Report on Form 10-K.
- · Prior to engaging S&E, the company did not consult S&E regarding accounting principles, audit opinions, or any matters that would be subject of a disagreement or reportable event.
- · BCRG provided a letter to the SEC dated June 23, 2026, agreeing with the statements in the filing, filed as Exhibit 16.1.
Get daily alerts with 8 investment signals, 9 risk alerts, 7 opportunities and full AI analysis of all 11 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Merger & Acquisition SEC Filings
🇺🇸 More from United States
View all →June 22, 2026
US Pre-Market SEC Filings Roundup — June 22, 2026
US Pre-Market SEC Filings Roundup
June 22, 2026
USA Insider Trading Pulse — June 22, 2026
USA Insider Trading Pulse
June 21, 2026
General Federal Contracts — June 21, 2026
General Federal Contracts
June 21, 2026
High-Value Federal Grants ($5M+) — June 21, 2026
High-Value Federal Grants ($5M+)